These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 18927587
1. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Du J, Liang X, Liu Y, Qu Z, Gao L, Han L, Liu S, Cui M, Shi Y, Zhang Z, Yu L, Cao L, Ma C, Zhang L, Chen Y, Sun W. Cell Death Differ; 2009 Feb; 16(2):219-29. PubMed ID: 18927587 [Abstract] [Full Text] [Related]
2. Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL. Liang X, Qu Z, Zhang Z, Du J, Liu Y, Cui M, Liu H, Gao L, Han L, Liu S, Cao L, Zhao P, Sun W. Biochem Biophys Res Commun; 2008 May 02; 369(2):456-63. PubMed ID: 18284918 [Abstract] [Full Text] [Related]
3. Hepatocytes treated with HBV X protein as cytotoxic effectors kill primary hepatocytes by TNF-alpha-related apoptosis-induced ligand-mediated mechanism. Yang Y, Zheng L, Lv G, Jin X, Sheng J. Intervirology; 2007 May 02; 50(5):323-7. PubMed ID: 17657161 [Abstract] [Full Text] [Related]
4. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, Chung YH. Cancer Gene Ther; 2009 May 02; 16(5):453-61. PubMed ID: 19096445 [Abstract] [Full Text] [Related]
5. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells. Kong F, You H, Zhao J, Liu W, Hu L, Luo W, Hu W, Tang R, Zheng K. Virol J; 2015 Nov 17; 12():192. PubMed ID: 26577955 [Abstract] [Full Text] [Related]
6. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Hum Pathol; 2005 Oct 17; 36(10):1066-73. PubMed ID: 16226105 [Abstract] [Full Text] [Related]
7. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T. Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136 [Abstract] [Full Text] [Related]
8. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, Zhang L, Chen YH, Sun W. J Immunol; 2007 Jan 01; 178(1):503-10. PubMed ID: 17182590 [Abstract] [Full Text] [Related]
9. Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model. Liu YG, Liu SX, Liang XH, Zhang Q, Gao LF, Han LH, Cao YL, Hou N, Du J, Sun WS. Biochem Biophys Res Commun; 2007 Jan 12; 352(2):329-34. PubMed ID: 17126290 [Abstract] [Full Text] [Related]
10. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Kwon JA, Rho HM. Biol Chem; 2003 Feb 12; 384(2):203-12. PubMed ID: 12675512 [Abstract] [Full Text] [Related]
11. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C. Gastroenterology; 2007 Nov 12; 133(5):1649-59. PubMed ID: 17983809 [Abstract] [Full Text] [Related]
12. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 12; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
13. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS. Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319 [Abstract] [Full Text] [Related]
14. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y, Zhang B. Mol Cancer Res; 2008 Dec 01; 6(12):1861-71. PubMed ID: 19074831 [Abstract] [Full Text] [Related]
15. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Lee JT, Lee TJ, Kim CH, Kim NS, Kwon TK. Cancer Lett; 2009 Jul 08; 279(2):185-92. PubMed ID: 19250737 [Abstract] [Full Text] [Related]
16. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line. Cao L, Li Y, Cheng F, Li S, Long D. Transplant Proc; 2006 Sep 08; 38(7):2207-9. PubMed ID: 16980044 [Abstract] [Full Text] [Related]
17. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS. J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244 [Abstract] [Full Text] [Related]
18. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E, Majano PL, Gómez-Gonzalo M, García-Monzón C, Moreno-Otero R, Levrero M, López-Cabrera M. Hepatology; 1998 Oct 15; 28(4):1013-21. PubMed ID: 9755238 [Abstract] [Full Text] [Related]
19. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D. FEBS J; 2008 Apr 15; 275(8):1925-36. PubMed ID: 18341587 [Abstract] [Full Text] [Related]
20. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Mundt B, Wirth T, Zender L, Waltemathe M, Trautwein C, Manns MP, Kühnel F, Kubicka S. Gut; 2005 Nov 15; 54(11):1590-6. PubMed ID: 16227360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]